0001209191-24-003785.txt : 20240222 0001209191-24-003785.hdr.sgml : 20240222 20240222142242 ACCESSION NUMBER: 0001209191-24-003785 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240220 FILED AS OF DATE: 20240222 DATE AS OF CHANGE: 20240222 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Giles Lisa M. CENTRAL INDEX KEY: 0001568850 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40591 FILM NUMBER: 24664168 MAIL ADDRESS: STREET 1: DURATA THERAPEUTICS, INC. STREET 2: 200 SOUTH WACKER DRIVE SUITE 2550 CITY: CHICAGO STATE: IL ZIP: 60606 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HCW Biologics Inc. CENTRAL INDEX KEY: 0001828673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 825024477 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 BUSINESS PHONE: 954-842-2024 MAIL ADDRESS: STREET 1: 2929 N COMMERCE PKWY CITY: MIRAMAR STATE: FL ZIP: 33025 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2024-02-20 0 0001828673 HCW Biologics Inc. HCWB 0001568850 Giles Lisa M. C/O HCW BIOLOGICS INC 2929 N. COMMERCE PARKWAY MIRAMAR FL 33025 1 0 0 0 0 Common Stock 2024-02-20 4 A 0 35715 1.40 A 35815 D The reporting person purchased these shares directly from the issuer in a private placement, which transaction is exempt from Section 16(b) in accordance with Rule 16b-3(d) promulgated under the Securities Exchange Act of 1934, as amended. /s/ Lisa M. Giles 2024-02-22